Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA)
Liver tumours are among the leading causes of cancer-related death worldwide and hepatocellular carcinoma (HCC) accounts for the vast majority of liver tumours. When detected at an early stage of disease, patients might still be eligible for surgical-based curative treatments. However, currently onl...
Main Authors: | Luca Quagliata, Manuel Schlageter, Cristina Quintavalle, Luigi Tornillo, Luigi M. Terracciano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-04-01
|
Series: | Microarrays |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3905/3/2/91 |
Similar Items
-
Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It
by: Aurélien Lacombe, et al.
Published: (2015-05-01) -
Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer
by: Sahar Hakamy, et al.
Published: (2021-01-01) -
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer
by: Sutian Jiang, et al.
Published: (2021-08-01) -
PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays
by: Gerardo Botti, et al.
Published: (2016-06-01) -
Image microarrays derived from tissue microarrays (IMA-TMA): New resource for computer-aided diagnostic algorithm development
by: Jennifer A Hipp, et al.
Published: (2012-01-01)